Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

Immunovant (NASDAQ:IMVT – Get Free Report) had its price target dropped by equities researchers at Guggenheim from $46.00 to ...

KBC Group NV boosted its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 60.1% in the 4th quarter, ...

Immunovant stock down on dismal third-quarter fiscal 2025 results. It is on track to initiate 10 studies on IMVT-1402 across various autoimmune indications.

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

Many people have experience with thyroid disorders, including celebrities. Gigi Hadid, Wendy Williams, and Oprah Winfrey have opened up about their thyroid health. The thyroid is a butterfly ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

It causes the body to make too much thyroid hormone. Immunovant is a member of the Roivant Sciences Ltd. (NASDAQ:ROIV) family of companies. Also Read: Vivek Ramaswamy-Founded Roivant’s Anti ...